BlissBio
Hangzhou
About BlissBio
Bliss Bio is a biopharmaceutical company focused on development of tumor targeting and immunotherapy drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $76.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2023)
- Website: blissbiopharma.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/blissbio-41693 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.